I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) shares rose 1.90% to $91.35, outperforming peers like Johnson & Johnson and Medtronic during a positive market session. This marks the second consecutive day of gains for ZBH, though it remains 15.64% below its 52-week high. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) rose 1.90% to $91.35 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.05% to 7,411.98 and the Dow Jones Industrial Average rising 0.46% to 51,947.25.
This was the stock's second consecutive day of gains.
Zimmer Biomet Holdings Inc. closed 15.64% short of its 52-week high of $108.29, which the company achieved on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.59% to $263.40, Medtronic PLC (MDT) rose 1.46% to $83.21, and Stryker Corp. (SYK) rose 3.54% to $330.25.
Trading volume (1.2 M) remained 1.0 million below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-24-26 1710ET